FDC.NS Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 apr 2024 @ 12:00):

Stats
Dagens volum	205 685
Gjennomsnittsvolum	262 208
Markedsverdi	75.15B
EPS	INR0 ( 2024-02-06 )
Neste inntjeningsdato	( INR0 ) 2024-05-22
Last Dividend	INR0.800 ( 2020-03-19 )
Next Dividend	INR0 ( N/A )
P/E	25.98
ATR14	INR0.538 (0.12%)

Volum Korrelasjon

Lang: -0.07 (neutral)

Kort: -0.78 (moderate negative)

Signal:(32.056) Neutral

FDC Limited Korrelasjon

10 Mest positive korrelasjoner
KOTAKBANK.NS	0.848
MAXVIL.NS	0.806

10 Mest negative korrelasjoner
GANGOTRI.NS	-0.83

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

FDC Limited Korrelasjon - Valuta/Råvare

0.04
( neutral )

-0.08
( neutral )

0.00
( neutral )

-0.19
( neutral )

-0.82
( strong negative )

0.34
( neutral )

FDC Limited Økonomi

Annual	2022
Omsetning:	INR17.84B
Bruttogevinst:	INR11.28B (63.24 %)
EPS:	INR11.67

FY	2022
Omsetning:	INR17.84B
Bruttogevinst:	INR11.28B (63.24 %)
EPS:	INR11.67

FY	2022
Omsetning:	INR15.26B
Bruttogevinst:	INR9.78B (64.12 %)
EPS:	INR12.82

FY	2021
Omsetning:	INR13.27B
Bruttogevinst:	INR9.00B (67.82 %)
EPS:	INR17.72

Financial Reports:

No articles found.

FDC Limited Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

FDC Limited Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 4.35 - low (44.58%) | Divividend Growth Potential Score: 4.17 - Potential for dividend initiation, but uncertain (16.61%)

Information

First Dividend	INR0.100	2002-08-19
Last Dividend	INR0.800	2020-03-19
Next Dividend	INR0	N/A
Payout Date	2020-03-26
Next Payout Date	N/A
# dividends	20	--
Total Paid Out	INR24.83	--
Avg. Dividend % Per Year	0.03%	--
Score	1.69	--
Div. Sustainability Score	4.35
Div.Growth Potential Score	4.17
Div. Directional Score	4.26	--

Next Divdend (Est)
(2024-09-06)

INR0 Estimate 0.00 %

Dividend Stability

0.05 Very Bad

Dividend Score

1.69

Pay Frequency

Sporadic

Yearly Payout

Year	Amount	Yield
2002	INR0	0.00%
2003	INR0	0.00%
2004	INR0	0.00%
2005	INR0	0.00%
2006	INR0	0.00%
2007	INR0	0.00%
2008	INR0	0.00%
2009	INR0	0.00%
2010	INR0	0.00%
2011	INR0	0.00%
2012	INR0	0.00%
2013	INR0	0.00%
2014	INR0	0.00%
2015	INR0	0.00%
2016	INR0	0.00%
2017	INR0	0.00%
2018	INR0	0.00%
2019	INR0	0.00%
2020	INR0.800	0.38%
2021	INR0	0.00%
2022	INR0	0.00%
2023	INR0	0.00%
2024	INR0	0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
SUTLEJTEX.NS	Dividend Junior	2023-08-18	Annually	18	1.03%
NDRAUTO.NS	Dividend Junior	2023-07-12	Annually	4	0.59%
ICICIGI.NS	Dividend Junior	2023-06-12	Annually	8	0.36%
CENTENKA.NS	Dividend Junior	2023-08-11	Annually	22	1.85%
RUBYMILLS.NS	Dividend Junior	2023-09-20	Annually	23	0.96%
LINCOLN.NS	Dividend Junior	2023-09-15	Annually	9	0.32%
GEECEE.NS	Dividend Junior	2023-09-08	Sporadic	18	0.97%
ARIHANTCAP.NS	Dividend Junior	2023-07-28	Annually	4	0.39%
TEXINFRA.NS	Dividend Junior	2023-09-18	Annually	20	0.18%
OPTIEMUS.NS	Dividend Junior	2023-06-07	Insufficient data to determine frequency	2	0.16%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.151	1.500	6.98	10.00	[0 - 0.5]
returnOnAssetsTTM	0	1.200	0	0	[0 - 0.3]
returnOnEquityTTM	0.147	1.500	9.48	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0	0.800	-5.00	-4.00	[1 - 3]
quickRatioTTM	0	0.800	-4.71	-3.76	[0.8 - 2.5]
cashRatioTTM	0	1.500	-1.111	-1.667	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	82.77	1.000	10.00	10.00	[3 - 30]
operatingCashFlowPerShareTTM	11.30	2.00	6.23	10.00	[0 - 30]
freeCashFlowPerShareTTM	7.82	2.00	6.09	10.00	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.657	1.000	2.38	2.38	[0.2 - 0.8]
operatingProfitMarginTTM	0.183	1.000	8.34	8.34	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				4.35

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	25.99	1.000	7.48	0	[1 - 100]
returnOnEquityTTM	0.147	2.50	9.67	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	7.82	2.00	7.39	10.00	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	11.30	2.00	6.23	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	1.568	1.500	2.88	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0960	1.000	-0.0998	0	[0.1 - 0.5]
Total Score				4.17

FDC Limited

FDC Limited manufactures and markets pharmaceutical products in India and internationally. The company offers specialized formulations for various therapeutic segments, including anti-infective, gastrointestinal, ophthalmological, vitamins/minerals/dietary supplements, cardiac, anti-diabetes, respiratory, gynecology, dermatology, analgesics, and others; and oral rehydration salts. It provides specialized formulations primarily under the Zifi, Electral, Enerzal, Vitcofol, Pyrimon, Zocon, Zoxan, Zathrin, Zipod, Zefu, Cotaryl, and Mycoderm brand names. The company also offers anti-oxidants, balanced energy drinks, and vitamins and nutraceuticals under the Enerzal, Humyl, Mum Mum 1, Prosoyal, Simyl-LBW, Simyl-MCT, and Zefrich brands. In addition, it provides various active pharmaceutical ingredients. FDC Limited was founded in 1936 and is headquartered in Mumbai, India.